Tegumentary leishmaniasis in childhood

Pediatric Dermatology

Volumn 13, Issue 6, 1996, Pages 455-463

  Bittencourt, Achiléa L ^a   Barral, Aldina ^a   Costa, Jackson M L ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; LEISHMANIA BRAZILIENSIS; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SKIN TUBERCULOSIS; SPOROTRICHOSIS;

EID: 0030474748     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.1996.tb00724.x     Document Type: Article

References (58)

1. Modabber F. The leishmaniases. In: Maurice J, Pearce AM, eds. Tropical diseases research, a global partnership. Eight Programme Report, TDR. Geneva: World Health Organization. 1987:99-112.
2. Bittencourt A, Barral-Netto M. Leishmaniasis. In: Doerr W, Seifert G. Tropical pathology. Heidelberg: Springer, 1995:597-651.
3. Barral A, Pedral-Sampaio D, Grimaldi G Jr, Momen H, McMahon-Pratt D. Jesus AR. Almeida R, Badaró R, Barral-Netto M, Carvalho EM, Johnson WD Jr. Leishmaniasis in Bahia-Brazil: evidence that L. amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991;44:536-546.
4. Grimaldi G Jr, Tesh R, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 1989;41:88-400.
5. Bonfante-Garrido R, Meléndez E, Barroeta S, Alejos MA. Momen H, Cupolillo E, McMahon-Pratt D, Grimaldi G Jr. Cutaneous leishmaniasis in western Venezuela caused by infection with L. veneznelensis and L. braziliensis variants. Trans R Soc Trop Med Hyg 1992;86:141-148.
6. Al-Gindan Y, Abdul-Azia O, Kubba R. Cutaneous leishmaniasis in Al-Hassa, Saudi Arabia. Int J Dermatol 1984;23:194-197.
7. Mengistu G, Laskay T, Gemetchu T, Humber D, Ersamo M, Evans D, Teferedegn H, Phelouzat MA, Frommel D. Cutaneous leishmaniasis in southwestern Ethiopia: Ocholo revisited. Trans R Soc Trop Med Hyg 1992;86:149-153.
8. Bryceson A. Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans Roy Soc Trop Med Hyg 1969;63:708-739.
9. Barrientos L. Um caso atípico de leishmaniose cutâneo-mucosa. Mem Inst Oswaldo Cruz 1948;46: 415-418.
10. Convit J, Kerdel-Vegas F, Gordon B. Disseminated anergic cutaneous leishmaniasis. Brit J Dermatol 1974;74:132-135.
11. Diaz H, Martinez Quinones M, Estévez F. Leishmaniose anérgica na Republica Dominicana. Estudo de 20 casos. An Bras Dermatol 1985;60(suppl. 1): 229-236.
12. Fonseca A, Araújo R, Fonseca W. Leishmaniose tegumentar difusa. Med Cut ILA 1981;IX:317-322.
13. Balzer R, Destombes P, Schaller K, Serie C. Leishmaniose cutaneé pseudolepromateuse on Éthiopie. Bull Soc Path Exot 1960;53:293-298.
14. Franke E, Lucas C, Tovar A. Kruger H, Rivera VS, Wignall FS. Diffuse cutaneous leishmaniasis acquired in Peru. Am J Trop Med Hyg 1990;43:260-262.
15. Marquez F. Leishmaniasis cutanea diseminada anérgica. Med Cut ILA 1966;3:287-292.
16. Nery-Guimarâes F. Estado atual dos conhecimentos da forma lepromatóide da leishmaniose tegumentar. Hospital 1965;67:57-76.
17. Portugal H, Marques A. Leishmaniose tegumentar difusa. Hospital 1960;57:11-21.
18. Rodriguez G, Conedor A, Caceres E, Cassiano G, Arroyo C, Palan MT, Boshell J. Leishmaniasis difusa. Biomédica 1985;5:95-111.
19. Silva AR, Mendes J, Rodrigues M, Carvalho ZS, Reis FM, Melo JE, Morais JC. Leishmaniose cutânea difusa (LCD). Registre de um caso em Buriticupu, Estado do Maranhão-Brasil. Rev Inst Med Trop São Paulo 1981;23:31-35.
20. Silva D, Maroja R, Salgado U, Loureiro A. Leishmaniose anérgica hansenóide. Dermatol Iber Latin Am 1972;4:493-505.
21. Simpson M, Mullins J, Stone O. Disseminated anergic cutaneous leishmaniasis. Arch Dermatol 1968;97: 301-303.
22. Zerega F. Sobre um caso de leishmaniasis tegumentaria difusa. Rev Ecuat Hig Med Trop 1961;18:18-20.
23. Takahashi S, Sato T. Disseminierte kutane leishmaniose. Hautarzt 1981;32:459-462.
24. Velasco O, Savarino S, Walton G, Gam A, Neva F. Diffuse cutaneous leishmaniasis in Mexico. Am J Trop Med Hyg 1989;41:280-288.
25. Titus RG, Sherry B, Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 1989;6:2097-2104.
26. Barral-Netto M, Barral A, Brownell CE, Skeiky YAW, Ellingsworth LK, Twardzik DR, Reed SG. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 1992;257: 545-548.
27. Barrai A, Barral-Netto M, Yong EC, Bronell CE, Twardzik DR, Reed SG. Transforming growth factor-β as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA 1993;90:3442-3446.
28. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1, -beta2, and -beta3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 1990; 145:940-944.
29. Moll H, Fuchs H, Blank C, Röllinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993; 23:1595-1601.
30. Cucé LC, Belda W Jr, Zolli CA. Leishmaniose tegumentar na infância. An Bras Dermatol 1990;65:185-195.
31. Griffiths WAD. Old World cutaneous leishmaniasis. In: Peters W, Killick-Kendrick R, eds. The leishmaniasis in biology and medicine. Clinical aspects and control. Vol. II. London: Academic Press, 1987:618-636.
32. Bittencourt AL, Costa JML, Carvalho EM, Barrai A. Leishmaniasis recidiva cutis in American cutaneous leishmaniasis. Int J Dermatol 1993;32:802-805.
33. Carvalho EM, Barrai A, Costa JML, Bittencourt AL, Marsden P. Clinical and immunological aspects in disseminated cutaneous leishmaniasis. Acta Tropica 1994;56:315-325.
34. Kubba R, El Hassan AM, Al Gindan Y, Omer AHS, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. I. Subcutaneous nodules. Int J Dermatol 1987;26:300-304.
35. Barrai A, Guerreiro J, Bonfim G, Correia D, Barral-Netto M, Carvalho EM. Lymphadenopathy as the first sign of human cutaneous infectioin by Leishmania braziliensis. Am J Trop Med Hyg 1995;53:256-259.
36. Al-Gindan Y, Kubba R, El Hassan EM, Omer AHS, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. 3. Lymph node enlargement. Int J Dermatol 1989;28:248-254.
37. Morierty PL, Bittencourt AL, Pereira C, et al. Borderline cutaneous leishmaniasis. Clinical, immunological and histological differences from mucocutaneous leishmaniasis. Rev Inst Med Trop São Paulo 1978;20:15-21.
38. Barrai A, Costa JML, Bittencourt AL, Barral-Netto M, Carvalho EM. Polar and subpolar diffuse cutaneous leishmaniasis in Brasil: clinical and immunopathological aspects. Int J Dermatol 1995;34:474-479.
39. Rees PH, Kager PA. Visceral leishmaniasis and postkala-azar dermal leishmaniasis. In: Peters W, Killick-Kendrick R, eds. The leishmaniases in biology and medicine. Vol. II. London: Academic Press, 1987;584-596.
40. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JLM, Reed S, Rocha H. Cell mediated immunity in American cutaneous and mucocutaneous leishmaniasis. J Immunol 1985;135:4144-4148.
41. Ridley DS, Ridley MJ. The evolution of the lesion in cutaneous leishmaniasis. J Pathol 1983;141:83-96.
42. Bittencourt AL, Barral A. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz 1991;86:51-56.
43. Ghalib HW, Eltoum EA, Kroon CCM, El Hassan AM. Identification of Leishmania from mucosal leishmaniasis by recombinant DNA probes. Trans R Soc Trop Med Hyg 1992;86:158-160.
44. Lopez M, Inga R, Cangalaya M, Echevarria J, Lianos-Cuentas A, Orrego C, Arevalo J. Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work. Am J Trop Med Hyg 1993;43:348-356.
45. Bittencourt A, Barrai A, Jesus A, Almeida RP, Grimaldi G Jr. In situ identification of Leishmania amazonensis associated with diffuse cutaneous leishmaniasis in Bahia, Brazil. Mem Inst Oswaldo Cruz 1989; 84:585-586.
46. Barral-Netto M, Machado P, Barrai A, Human cutaneous leishmaniasis: recent advances in physiopathology and treatment. Eur J Dermatol 1995;5:104-113.
47. Marsden PD. Mucosal leishmaniasis due to Leishmania (vianna) braziliensis L(v)b in Três Braços, Bahia-Brazil Rev Soc Bras Med Trop 1994;27:93-101.
48. Costa JML, Saldanha ACR, Silva ACM, Serra Neto A, Galvão CES, Pedroso e Silva AR. Estado atual da leishmaniose cutânea difusa (LCD) no estado do Maranhão. II. Aspectos epidemiológicos, clínicos-evolutivos. Rev Soc Bras Med Trop 1992;25:115-123.
49. Soto-Mancipe J, Grogl M, Berman JD. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 1993;16:417-425.
50. Costa JML, Sampaio RN, Tada MS, Almeida EA, Veiga EP, Magalhães AV, Marsden PD. Furazolidone treatment of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1985;79:274.
51. Barrios LA, Costa JML, Netto EM, Vexenat A, Cuba Cuba CA, Marsden PD. Intralesional glucantime in Leishmania braziliensis braziliensis infections. Trans R Soc Trop Med Hyg 1986;80:173-174.
52. Kellum RE. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam). J Am Acad Dermatol 1986;15:620-622.
53. Krause G, Kroeger A. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg 1994;88:92-94.
54. El-On J, Weinrauch L, Livshin R, Even-Paz Z, Jacobs GP. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paramomycin and methylbenzethonium chloride. Brit Med J 1985; 291:704-705.
55. Asilian A, Jalayer T, Whiteworth JAG, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paramomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 1995;53:648-651.
56. Costa JML, Barrios LA, Netto EM, Marsden PD. Topical Pentostam in attempt to produce more rapid healing of skin ulcers due to Leishmania braziliensis braziliensis ulcers. Rev Soc Bras Med Trop 1986;19: 199-200.
57. Moray TA, Abedel-Rahman EG, Ahmed AM. Treatment of cutaneous leishmaniasis with Pentostam or cryosurgery. J Egypt Soc Parasit 1989;19:533-534.
58. Bittencourt AL, Badaró R, Costa J, Barrai A, Badaró F, Carvalho EM. Effect of pentavalent antimonial and IFN-γ treatment on the histopathological and ultrastructural aspects of diffuse cutaneous leishmaniasis due to Leishmania amazonensis. Eur J Dermatol 1996;6(4)264-267.